136 related articles for article (PubMed ID: 29085992)
1. T2 signal intensity as an imaging biomarker for patients with superficial Fibromatoses of the hands (Dupuytren's disease) and feet (Ledderhose disease) undergoing definitive electron beam irradiation.
Banks JS; Wolfson AH; Subhawong TK
Skeletal Radiol; 2018 Feb; 47(2):243-251. PubMed ID: 29085992
[TBL] [Abstract][Full Text] [Related]
2. Superficial fibromatosis: MRI radiomics and T2 mapping correlate with treatment response.
Ramachandran A; Fox T; Wolfson A; Banks J; Subhawong TK
Magn Reson Imaging; 2021 Sep; 81():53-59. PubMed ID: 34116132
[TBL] [Abstract][Full Text] [Related]
3. Dupuytren's contracture: MR imaging findings and correlation between MR signal intensity and cellularity of lesions.
Yacoe ME; Bergman AG; Ladd AL; Hellman BH
AJR Am J Roentgenol; 1993 Apr; 160(4):813-7. PubMed ID: 8456670
[TBL] [Abstract][Full Text] [Related]
4. [Fibromatosis plantaris Ledderhose (Dupuytren's contracture of the foot sole].
Villiger KJ
Schweiz Med Wochenschr; 1982 May; 112(18):653-8. PubMed ID: 7079701
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib in Dupuytren and Ledderhose Disease.
Schoenfeld JD; Agaram NP; Lefkowitz RA; Kelly CM; Healey JH; Gounder MM
Oncologist; 2022 Mar; 27(3):e294-e296. PubMed ID: 35274715
[TBL] [Abstract][Full Text] [Related]
6. Desmoid fibromatosis: MRI features of response to systemic therapy.
Sheth PJ; Del Moral S; Wilky BA; Trent JC; Cohen J; Rosenberg AE; Temple HT; Subhawong TK
Skeletal Radiol; 2016 Oct; 45(10):1365-73. PubMed ID: 27502790
[TBL] [Abstract][Full Text] [Related]
7. Radiation therapy for early stages of morbus Ledderhose.
Heyd R; Dorn AP; Herkströter M; Rödel C; Müller-Schimpfle M; Fraunholz I
Strahlenther Onkol; 2010 Jan; 186(1):24-29. PubMed ID: 20082184
[TBL] [Abstract][Full Text] [Related]
8. [Radiation therapy for Morbus Ledderhose -- indication and clinical results].
Seegenschmiedt MH; Attassi M
Strahlenther Onkol; 2003 Dec; 179(12):847-53. PubMed ID: 14652674
[TBL] [Abstract][Full Text] [Related]
9. Does collagenase injection disrupt or digest the Dupuytren's cord: a magnetic resonance imaging study.
Crivello KM; Potter HG; Moon ES; Rancy SK; Wolfe SW
J Hand Surg Eur Vol; 2016 Jul; 41(6):614-20. PubMed ID: 26768221
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy with soft X-rays in Dupuytren's disease - successful, well-tolerated and satisfying.
Zirbs M; Anzeneder T; Bruckbauer H; Hofmann H; Brockow K; Ring J; Eberlein B
J Eur Acad Dermatol Venereol; 2015 May; 29(5):904-11. PubMed ID: 25201324
[TBL] [Abstract][Full Text] [Related]
11. A case study of radiotherapy treatment for Dupuytren's contracture and Ledderhose disease.
Solie P; Stump B; Cashner C; Lenards N; Hunzeker A; Zeiler S
Med Dosim; 2023 Autumn; 48(3):149-153. PubMed ID: 37059629
[TBL] [Abstract][Full Text] [Related]
12. Clinical features and management of superficial fibromatoses.
Kelenjian S; Mattjie RA; Franz R; Biedermann T; Brockow K
J Dtsch Dermatol Ges; 2019 Apr; 17(4):393-397. PubMed ID: 30865379
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for patients with Ledderhose disease: Long-term effects, side effects and patient-rated outcome.
de Haan A; van Nes JGH; Werker PMN; Langendijk JA; Steenbakkers RJHM
Radiother Oncol; 2022 Mar; 168():83-88. PubMed ID: 35101465
[TBL] [Abstract][Full Text] [Related]
14. Partial fasciectomy is a useful treatment option for symptomatic plantar fibromatosis.
Kadir HKA; Chandrasekar CR
Foot (Edinb); 2017 Jun; 31():31-34. PubMed ID: 28334642
[TBL] [Abstract][Full Text] [Related]
15. Can the MRI signal of aggressive fibromatosis be used to predict its behavior?
Castellazzi G; Vanel D; Le Cesne A; Le Pechoux C; Caillet H; Perona F; Bonvalot S
Eur J Radiol; 2009 Feb; 69(2):222-9. PubMed ID: 19046842
[TBL] [Abstract][Full Text] [Related]
16. [An attempt to objectify the assessment of extension or recurrence of Dupuytren's disease on the basis of ultrasound].
Bednarek M; Trybus M; Wiśniowski Z; Budzyński P; Gniadek M
Przegl Lek; 2012; 69(12):1266-70. PubMed ID: 23750436
[TBL] [Abstract][Full Text] [Related]
17. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
[TBL] [Abstract][Full Text] [Related]
18. Neuroimaging and quality-of-life outcomes in patients with brain metastasis and peritumoral edema who undergo Gamma Knife surgery.
Pan HC; Sun MH; Chen CC; Chen CJ; Lee CH; Sheehan J
J Neurosurg; 2008 Dec; 109 Suppl():90-8. PubMed ID: 19123894
[TBL] [Abstract][Full Text] [Related]
19. Clinics in diagnostic imaging (195). Plantar fibromatosis.
Teo F; Mohamed Shah MT; Wong BSS
Singapore Med J; 2019 May; 60(5):230-235. PubMed ID: 31187147
[TBL] [Abstract][Full Text] [Related]
20. Imaging of musculoskeletal fibromatosis.
Robbin MR; Murphey MD; Temple HT; Kransdorf MJ; Choi JJ
Radiographics; 2001; 21(3):585-600. PubMed ID: 11353108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
